News & Publications Supplementation with essential phospholipids lowered liver-fat markers in fatty liver disease
Supplementary information Supplementary Table 1 (download XLSX RNA-sequencing analysis of Ndusf2-KO and Bmal1-KO fractionated adipocytes, related to Fig
1-sided p-value evaluated at 2.5% level for superiority 14.4 Safety Outcomes Trial DEVOTE (NCT01959529) Cardiovascular Outcomes Trial of TRESIBA Administered Once-Daily Between Dinner and Bedtime in Combination with Standard of Care in Subjects with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease DEVOTE was a multi-center, multi-national, randomized, double-blinded, active-controlled, treat-to-target, event-driven trial
Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy
The published mechanistic literature has converged on the HGF/c-Met receptor system as the primary molecular target, with downstream effects on dendritic synaptogenesis and PI3K/AKT signaling
But it was about so much more than just this
